Immunobiology · 2026
Potent improvement in the immunomodulatory effects of mesenchymal stromal/stem cells following treatment with Mesobuthus eupeus whole venom and F1 fraction.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sadeghi Mahvash, Mohammadi Mojgan, Charoghdoozi Kianush, Ghoryani Mohsen, Nemati Mohammad, Afshari Jalil Tavakol, Dehnavi Sajad
Аннотация
INTRODUCTION: This study was evaluated the impact of Mesobuthus eupeus (M. eupeus) whole venom and its derived fractions on the expression levels of immunomodulatory and functional factors of mesenchymal stem cells (MSC) and their capacity to induce regulatory T cells (Treg) through small extracellular vesicle (sEV) mechanisms.
MATERIALS AND METHODS: Human umbilical cord-derived MSCs (UC-MSC) from a single healthy full-term mother were treated over a 24-h period with 100 μg/mL of whole venom (WV), F1, F2, F3, and F4 fractions, separately (in triplicate). Then, the expression of Galectin1, Galectin 3, Galectin 8, TLR2, TLR4, IL-10, TGF-β, HGF, IDO, SOX2, and OCT4 were evaluated through SYBR Green real-time polymerase chain reaction (PCR). Next, peripheral blood mononuclear cells (PBMC) were isolated from five healthy subjects and treated 24 h by sEVs derived from venom- and fraction-treated MSCs (in triplicate) and the percentage of regulatory T cells (Treg) were assessed through flow cytometry.
RESULTS: WV and F1 have significant effects on the gene expressions and sEV-treated Treg induction, while no significant changes were observed following F2, F3, and F4 treatments.
CONCLUSION: WV and F1 fraction could potentially administer as a pre-treatment agent to improve the immunomodulatory and immune-regulatory effects of MSCs.
MATERIALS AND METHODS: Human umbilical cord-derived MSCs (UC-MSC) from a single healthy full-term mother were treated over a 24-h period with 100 μg/mL of whole venom (WV), F1, F2, F3, and F4 fractions, separately (in triplicate). Then, the expression of Galectin1, Galectin 3, Galectin 8, TLR2, TLR4, IL-10, TGF-β, HGF, IDO, SOX2, and OCT4 were evaluated through SYBR Green real-time polymerase chain reaction (PCR). Next, peripheral blood mononuclear cells (PBMC) were isolated from five healthy subjects and treated 24 h by sEVs derived from venom- and fraction-treated MSCs (in triplicate) and the percentage of regulatory T cells (Treg) were assessed through flow cytometry.
RESULTS: WV and F1 have significant effects on the gene expressions and sEV-treated Treg induction, while no significant changes were observed following F2, F3, and F4 treatments.
CONCLUSION: WV and F1 fraction could potentially administer as a pre-treatment agent to improve the immunomodulatory and immune-regulatory effects of MSCs.